• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兔实验性聚合物贮积病。鞘脂类贮积症组织发生学的研究方法。

Experimental polymer storage disease in rabbits. An approach to the histogenesis of sphingolipidoses.

作者信息

Miyasaki K

出版信息

Virchows Arch A Pathol Anat Histol. 1975;365(4):351-65. doi: 10.1007/BF00471182.

DOI:10.1007/BF00471182
PMID:803739
Abstract

Water-soluble polymer compound, polyvinyl alcohol(PVA), and water-insoluble polymer compounds, polyvinyl acetate (PVAc) and polystylol (PS), were administered in 297 rabbits. When high polymerized PVA, PVAc or PS were continuously injected intravenously for a long period of time, lesions resembled to those of Gaucher and Niemann-Pick diseases were developed. From these experimental results, pathological development of various sphingolipidoses found in the human body was discussed and pathological findings were analysed polymer-chemically from the chemical properties of the substances stored.

摘要

将水溶性高分子化合物聚乙烯醇(PVA)以及水不溶性高分子化合物聚醋酸乙烯酯(PVAc)和聚苯乙烯(PS)注射到297只兔子体内。当长时间连续静脉注射高度聚合的PVA、PVAc或PS时,会出现类似于高雪氏病和尼曼-匹克病的病变。根据这些实验结果,对人体中发现的各种鞘脂类疾病的病理发展进行了讨论,并根据所储存物质的化学性质从高分子化学角度分析了病理结果。

相似文献

1
Experimental polymer storage disease in rabbits. An approach to the histogenesis of sphingolipidoses.兔实验性聚合物贮积病。鞘脂类贮积症组织发生学的研究方法。
Virchows Arch A Pathol Anat Histol. 1975;365(4):351-65. doi: 10.1007/BF00471182.
2
Progress in investigations of sphingolipidoses.鞘脂类贮积病的研究进展
Acta Neuropathol. 1978 Aug 7;43(1-2):1-18. doi: 10.1007/BF00684994.
3
[Comparative study of 3 types sphingolipidosis: Gaucher's disease, Niemann-Pick disease and the "sea-blue" histiocyte syndrome: cytology, ultrastructure and cytochemistry].
Arch Inst Pasteur Tunis. 1982 Jun-Sep;59(2-3):283-301.
4
Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.脂质贮积病:第二部分。鞘脂类沉积症中脂质贮积细胞的超微结构病理学。
Acta Pathol Jpn. 1985 Mar;35(2):385-408.
5
[Use of the electron microscope in the diagnosis of various metabolic storage diseases].[电子显微镜在各种代谢性贮积病诊断中的应用]
Minerva Pediatr. 1982 Feb 28;34(4):139-50.
6
Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.华东地区溶酶体贮积症亚型的人口统计学特征和分布。
J Hum Genet. 2016 Apr;61(4):345-9. doi: 10.1038/jhg.2015.155. Epub 2016 Jan 7.
7
[The Niemann-Pick cell. Aspects in optical and ultrastructural cytology].[尼曼-匹克细胞。光学和超微结构细胞学方面]
Pathol Biol (Paris). 1973 May;21(5):483-96.
8
Enzymatic diagnosis of sphingolipidoses.鞘脂贮积症的酶学诊断
Methods Enzymol. 1987;138:727-62. doi: 10.1016/0076-6879(87)38063-2.
9
Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses.戈谢病:了解鞘脂贮积症的分子发病机制
J Inherit Metab Dis. 2001;24 Suppl 2:106-21; discussion 87-8. doi: 10.1023/a:1012496514170.
10
An autopsy case of Niemann-Pick disease.一例尼曼-匹克病尸检病例。
Acta Pathol Jpn. 1973 Nov;23(4):837-46. doi: 10.1111/j.1440-1827.1973.tb02779.x.

引用本文的文献

1
Surface engineering of liposomes for stealth behavior.脂质体的表面工程实现隐形行为。
Pharmaceutics. 2013 Oct 25;5(4):542-69. doi: 10.3390/pharmaceutics5040542.
2
Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.脂质体特性和剂量对聚氨基酸包被脂质体药代动力学的影响。
Pharm Res. 2007 Dec;24(12):2394-401. doi: 10.1007/s11095-007-9393-2. Epub 2007 Aug 3.
3
Fully degradable hydrophilic polyals for protein modification.用于蛋白质修饰的完全可降解亲水性聚缩醛

本文引用的文献

1
EVIDENCE FOR THE GENETIC BLOCK IN METACHROMATIC LEUCODYSTROPHY (ML).异染性脑白质营养不良(ML)中基因阻断的证据。
Biochem Biophys Res Commun. 1965 May 3;19:407-11. doi: 10.1016/0006-291x(65)90137-3.
2
METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.葡萄糖脑苷脂的代谢。II. 戈谢病中酶缺乏的证据。
Biochem Biophys Res Commun. 1965 Jan 18;18:221-5. doi: 10.1016/0006-291x(65)90743-6.
3
ULTRASTRUCTURAL AND BIOCHEMICAL OBSERVATIONS ON A CASE OF SYSTEMIC LATE INFANTILE LIPIDOSIS AND ITS RELATIONSHIP TO TAY-SACHS DISEASE AND GARGOYLISM.
Biomacromolecules. 2005 Sep-Oct;6(5):2648-58. doi: 10.1021/bm049210k.
一例全身性晚发性婴儿脂质沉积症的超微结构及生化观察及其与泰-萨克斯病和黏多糖贮积症的关系
J Neuropathol Exp Neurol. 1965 Apr;24:318-40. doi: 10.1097/00005072-196504000-00011.
4
GENERALIZED GANGLIOSIDOSIS: ANOTHER INBORN ERROR OF GANGLIOSIDE METABOLISM?全身性神经节苷脂沉积症:另一种神经节苷脂代谢的先天性缺陷?
Am J Dis Child. 1965 Apr;109:338-46.
5
THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE.葡萄糖脑苷脂的代谢。I. 从脾脏组织中分离纯化一种葡萄糖脑苷脂裂解酶及其性质
J Biol Chem. 1965 Jan;240:39-43.
6
A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM.三项人类糖脂代谢紊乱中酶活性的对照研究。
J Neurochem. 1963 Dec;10:805-16. doi: 10.1111/j.1471-4159.1963.tb11905.x.
7
Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.法布里病的酶缺陷。神经酰胺三己糖苷酶缺乏症。
N Engl J Med. 1967 May 25;276(21):1163-7. doi: 10.1056/NEJM196705252762101.
8
The metabolism of ceramide trihexosides. I. Purification and properties of an enzyme that cleaves the terminal galactose molecule of galactosylgalactosylglucosylceramide.神经酰胺三己糖苷的代谢。I. 一种能切割半乳糖基半乳糖基葡萄糖基神经酰胺末端半乳糖分子的酶的纯化及特性
J Biol Chem. 1967 Mar 10;242(5):1021-6.
9
The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue.鞘磷脂的代谢。I. 从大鼠肝脏组织中纯化鞘磷脂裂解酶及其性质
J Biol Chem. 1966 Mar 10;241(5):1081-4.
10
Cerebroside galactosidase of brain.脑苷脂半乳糖苷酶(存在于脑内)
J Lipid Res. 1966 May;7(3):379-86.